Lymphoma (includes NHL, HL, CNS Lymphoma)
Featured Articles
(ASH) June 15, 2018 - Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.
Read Article
(FDA.gov) June 13, 2018 - On June 13, 2018, the Food and Drug Administration granted accelerated approval to pembrolizumab (Keytruda, Merck) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after two or more prior lines of therapy.
Read Article
Latest Articles
June 19, 2018
June 18, 2018
June 18, 2018
June 18, 2018
June 18, 2018
June 15, 2018
June 15, 2018
June 15, 2018
View More
News Commentary
Editor Image
05 Oct, 2017 | by Dean Gesme, MD
An excellent editorial this past week in JCO authored by Jim Armitage and Dan...
View Comment
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) blog entries.